Wrap-up of Rollover Process and Timeline

The rollover consent form and process will conclude on June 15, 2021!

As part of the transition to the SOR II grant in October 2020, OMNI launched the rollover consent form to allow for an easy transition of SOR I client GPRA information into the SOR II grant period, for those continuing to receive SOR-funded services in the SOR II period.

Process:

  • For clients who have already completed their follow-up GPRA from SOR I, complete the rollover consent form at the client's next scheduled appointment.

  • For clients who have not yet completed their follow-up GPRA from SOR I, complete the rollover consent form at their follow-up GPRA interview.

Timeline:

  • The 8-month no-cost extension of the SOR I grant for follow-up GPRAs will conclude at the end of May 2021 with all SOR I follow-up windows closing after May 31, 2021). As such, the rollover consent form will close two weeks after this on June 15, 2021.

  • After June 15, 2021, you will no longer be able to roll clients from SOR I to SOR II using the rollover consent form and will have to complete a new SOR II intake GPRA interview. Please be sure to complete the rollover form for all SOR I clients continuing to receive SOR II-funded services before June 15, 2021.

Please reach out to SORSupport@omni.org with any questions or needed support!

https://www.ecfr.gov/current/title-2/subtitle-A/chapter-II/part-200#200.112 Per 2 C.F.R. § 200.112-1113 The Federal awarding agency must establish conflict of interest policies for Federal awards. The non-Federal entity must disclose in writing any potential conflict of interest to the Federal awarding agency or pass-through entity in accordance with applicable Federal awarding agency policy. Failure to adhere to these statues will result in immediate termination of funding.

Virginia’s State Opioid Response (SOR) grant is awarded at the discretion of DBHDS and SAMHSA. All recipients of SOR funding supports evidence-based prevention, treatment and recovery services to address opioid and stimulant misuse and use disorders, including for cocaine and methamphetamine. The SOR grant is not intended to be utilized as a long-term or permanent funding source. All SOR proposals must include a realistic plan for financial sustainability beyond the grant period.